Today: 19 May 2026
Qualcomm stock dips after-hours as tariff jitters hit tech; Nvidia earnings and QCOM dividend date ahead
24 February 2026
1 min read

Qualcomm stock dips after-hours as tariff jitters hit tech; Nvidia earnings and QCOM dividend date ahead

New York, February 23, 2026, 18:46 EST — Trading after the bell

Qualcomm Incorporated (QCOM.O) dropped $2.44, or 1.7%, to $140.41 in late after-hours trading on Monday. Shares earlier moved between $139.66 and $144.01 during the regular U.S. session.

Stocks slid after President Donald Trump announced a temporary tariff hike from 10% to 15%, a response to the Supreme Court decision curbing his powers on broad import levies. Investors rotated out of risk assets, steering clear of technology shares facing fresh threats from emerging AI tools. Pressure on those names lingered.

The Dow slipped 1.66%, while the S&P 500 lost 1.04% and the Nasdaq gave up 1.13%, according to Reuters. “You’ve seen the market react to headlines, it’s ‘sell first, assess later,’” said Tom Hainlin, national investment strategist at U.S. Bank Wealth Management. Traders are zeroing in on Nvidia’s quarterly numbers, due out Wednesday, February 25. Reuters

Qualcomm’s still dealing with the fallout from its guidance cut earlier this month. Now, the company is projecting revenue between $10.2 billion and $11 billion for the current quarter, and expects adjusted EPS to land in the $2.45 to $2.65 range. The culprit: a memory chip shortage, which Qualcomm says is holding up smartphone production for clients like Apple and other big Android makers. “I just wish we had more memory,” CEO Cristiano Amon told Reuters. Bob O’Donnell at TECHnalysis Research doesn’t see relief coming fast, warning the supply squeeze could drag on “the next several quarters.” Reuters

Qualcomm lagged behind other chip names on Monday, despite Nvidia finishing in the green. Broadcom and Intel slipped too, but their declines weren’t as steep as Qualcomm’s. Roughly 8.2 million Qualcomm shares changed hands—about 1.5 million below the 50-day average, according to MarketWatch data. The stock is now trading nearly 32% off its 52-week peak of $205.95.

Investors are eyeing Qualcomm’s push into custom AI chips. While Evercore still calls Broadcom “best-in-class” for this segment, the firm notes that Qualcomm is starting to gain traction, per Seeking Alpha. Seeking Alpha

Still, the immediate threat remains. Qualcomm execs warn that the memory shortage may persist through this fiscal year, possibly extending those supply constraints into 2027. That scenario could continue to restrict demand for smartphone chips, even if shoppers are looking to buy.

There’s a key shareholder date on the calendar. Qualcomm plans to hand out its regular cash dividend—89 cents per share—on March 26. But to get the payment, investors must be on record as of the close on March 5. That’s the date that determines eligibility for the dividend.

Nvidia’s earnings are on deck for Feb. 25, a date traders have circled, especially with fresh tariff news in play that could shake up the sector. For Qualcomm, those holding shares are keeping close tabs as the March 5 dividend record date approaches, eyeing the stock’s moves up to then.

Stock Market Today

  • When Will Island Pharmaceuticals Limited (ASX:ILA) Reach Profitability?
    May 19, 2026, 3:26 AM EDT. Island Pharmaceuticals Limited (ASX:ILA), a drug repurposing company focusing on antiviral therapeutics in Australia and the U.S., posted a AU$3.9 million loss in the latest financial year and a AU$7.2 million loss over the trailing twelve months. Analysts project the company will break even in 2027 and reach a profit of AU$295 million by 2028. This forecast implies an ambitious average annual growth rate of 140%. Notably, Island Pharmaceuticals operates with no debt, relying solely on shareholder funding, which reduces financial risk typical in cash-burning pharmaceutical firms. Investors anticipate milestone developments but should remain cautious of the high growth assumptions given the volatile nature of pharmaceutical cash flows during drug development phases.

Latest articles

Nasdaq gives up after-hours gains as oil and yields weigh on Wall Street rally

Nasdaq gives up after-hours gains as oil and yields weigh on Wall Street rally

19 May 2026
Dominion Energy shares jumped 9.4% after agreeing to an all-stock merger with NextEra Energy, whose shares fell 4.6%. The S&P 500 slipped 0.1% and the Nasdaq dropped 0.5% as investors sold technology stocks amid rising Treasury yields and oil prices. Nvidia fell 1.4% ahead of earnings. U.S. crude settled at $107.37, and the 10-year Treasury yield reached 4.59%.
XP Shares Slip Post-Q1, Buyback Fails to Sway Investors

XP Shares Slip Post-Q1, Buyback Fails to Sway Investors

19 May 2026
XP Inc.’s U.S.-listed shares fell 3.78% in after-hours trading Monday after reporting higher Q1 profit but weaker net inflows and a lower retail take rate. Net income rose 7% to 1.32 billion reais, but net inflow dropped to 14 billion reais from 24 billion a year earlier. The company declared a $0.20 dividend and announced a new CFO, Gustavo Alejo Viviani, starting August 3.
LiveRamp Rallies 27% After Publicis $2.5 Billion Cash Bid

LiveRamp Rallies 27% After Publicis $2.5 Billion Cash Bid

19 May 2026
Publicis Groupe agreed to buy LiveRamp Holdings for $38.50 a share in cash, valuing the U.S. data-collaboration firm at $2.546 billion. LiveRamp stock jumped to $37.77 on the news, while the broader market fell. LiveRamp reported fiscal Q4 revenue of $206 million, up 9% from a year earlier. Publicis said the deal will boost its adjusted earnings per share from the first year after closing.

Popular

ServiceNow Jumps After Wall Street Shifts AI View

ServiceNow Jumps After Wall Street Shifts AI View

19 May 2026
ServiceNow shares surged 8.8% to $103.42 Monday after Bank of America reinstated coverage with a Buy rating and $130 target. Volume hit 50.74 million shares, nearly double the average. The move contrasted with a broader tech selloff as the Nasdaq fell 0.51%. ServiceNow remains down about a third this year despite strong Q1 subscription revenue and raised guidance.
Salesforce stock (CRM) steadies, but Wall Street trims targets again ahead of Feb. 25 results
Previous Story

Salesforce stock (CRM) steadies, but Wall Street trims targets again ahead of Feb. 25 results

Shell share price today: What to watch before London opens as oil jumps and buybacks roll on
Next Story

Shell share price today: What to watch before London opens as oil jumps and buybacks roll on

Go toTop